Quarterly report pursuant to Section 13 or 15(d)

SHAREHOLDERS EQUITY (Details Narrative)

v3.21.2
SHAREHOLDERS EQUITY (Details Narrative) - USD ($)
1 Months Ended 2 Months Ended 3 Months Ended 6 Months Ended
May 14, 2021
May 06, 2021
May 21, 2020
May 31, 2021
Mar. 31, 2021
Jun. 30, 2021
Jun. 30, 2020
Common stock shares issued during the period, shares   3,507,164   8,962,500      
Proceeds from issuance of share       $ 1,792,500   $ 1,792,500 $ 94,048
Price per share   $ 1.14          
Medi Scans Founder [Member]              
Capital contribution description     Medi-Scan entered into agreement with Storm Funding LLC, a company owned by David Rubin. Storm Funding LLC committed to invest $250,000 in exchange for a 25% membership interest in Medi-Scan.   Medi-Scan's founders contributed $4,558 during the three months ended March 31, 2021, and $28,500 during the three months ended March 31, 2020.    
Series A Preferred Stock [Member] | Exchange Agreement With Richard Parker [Member]              
Ownership percentage 18.75%            
Shares surrendered, shares 29,407            
Common stock shares issued to related party 6,000,000            
Additional shares issued, shares 250,000            
Healthtech Solutions [Member] | Series C Preferred Stock [Member]              
Liquidation preference           4.90%  
Ownership percentage           4.90%  
Description of related party loan           The percentage ownership of Healthtech Oncology that the Series C Shareholders will obtain if they exchange their Series C Shares will depend on the amount of cash loaned by Healthtech Solutions to Healthtech Oncology: ranging from 85% ownership, if Healthtech Solutions loans $10 million to Healthtech Oncology, to 100% if Healthtech Solutions makes no loans to Healthtech Oncology. The Series C Shareholders may exchange their shares after April 1, 2023  
Series A, Preferred Stock              
Preferred share conversion term           Each share of Series A Preferred Stock is convertible by the holder into two thousand (2,000) shares of Common Stock.  
Preferred stock voting rights           Each share of Series A Preferred Stock entitles a stockholder to voting rights equivalent to those of 2,000 shares of Common Stock on all matters upon which stockholders are permitted to vote.  
Preferred stock liquidation preference           $ 0.01